These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity. Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204 [TBL] [Abstract][Full Text] [Related]
24. Stereotactic body radiation therapy for centrally located lung lesions. Joyner M; Salter BJ; Papanikolaou N; Fuss M Acta Oncol; 2006; 45(7):802-7. PubMed ID: 16982543 [TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936 [TBL] [Abstract][Full Text] [Related]
26. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260 [TBL] [Abstract][Full Text] [Related]
28. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Onimaru R; Shirato H; Shimizu S; Kitamura K; Xu B; Fukumoto S; Chang TC; Fujita K; Oita M; Miyasaka K; Nishimura M; Dosaka-Akita H Int J Radiat Oncol Biol Phys; 2003 May; 56(1):126-35. PubMed ID: 12694831 [TBL] [Abstract][Full Text] [Related]
29. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Brown WT; Wu X; Fayad F; Fowler JF; García S; Monterroso MI; de la Zerda A; Schwade JG Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):623-31. PubMed ID: 19682875 [TBL] [Abstract][Full Text] [Related]
30. Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy. Loi M; Franceschini D; Dominici L; Chiola I; Franzese C; D'Agostino GR; Navarria P; Marzo M; Paganini L; Comito T; Mancosu P; Tomatis S; Cozzi L; Alifano M; Scorsetti M Strahlenther Onkol; 2021 May; 197(5):396-404. PubMed ID: 32970163 [TBL] [Abstract][Full Text] [Related]
31. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607 [TBL] [Abstract][Full Text] [Related]
32. A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer. Abe T; Ryuno Y; Iino M; Saito S; Aoshika T; Ohta T; Igari M; Hirai R; Kumazaki Y; Kaira K; Kagamu H; Ishida H; Noda SE; Kato S Jpn J Clin Oncol; 2021 Dec; 51(12):1723-1728. PubMed ID: 34580722 [TBL] [Abstract][Full Text] [Related]
33. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lee SW; Choi EK; Park HJ; Ahn SD; Kim JH; Kim KJ; Yoon SM; Kim YS; Yi BY Lung Cancer; 2003 Jun; 40(3):309-15. PubMed ID: 12781430 [TBL] [Abstract][Full Text] [Related]
34. CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures. Oermann E; Collins BT; Erickson KT; Yu X; Lei S; Suy S; Hanscom HN; Kim J; Park HU; Eldabh A; Kalhorn C; McGrail K; Subramaniam D; Jean WC; Collins SP J Hematol Oncol; 2010 Jun; 3():22. PubMed ID: 20534128 [TBL] [Abstract][Full Text] [Related]
35. The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors. Nishizaki T; Saito K; Jimi Y; Harada N; Kajiwara K; Nomura S; Ishihara H; Yoshikawa K; Yoneda H; Suzuki M; Gibbs IC Minim Invasive Neurosurg; 2006 Aug; 49(4):203-9. PubMed ID: 17041830 [TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry. Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848 [TBL] [Abstract][Full Text] [Related]
37. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors. Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842 [TBL] [Abstract][Full Text] [Related]
38. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife. Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136 [TBL] [Abstract][Full Text] [Related]
39. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Collins BT; Erickson K; Reichner CA; Collins SP; Gagnon GJ; Dieterich S; McRae DA; Zhang Y; Yousefi S; Levy E; Chang T; Jamis-Dow C; Banovac F; Anderson ED Radiat Oncol; 2007 Oct; 2():39. PubMed ID: 17953752 [TBL] [Abstract][Full Text] [Related]
40. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning. Coon D; Gokhale AS; Burton SA; Heron DE; Ozhasoglu C; Christie N Clin Lung Cancer; 2008 Jul; 9(4):217-21. PubMed ID: 18650169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]